MolMed acute leukaemias: Contribution of TK presented at the BMT Tandem …GroundReportMolMed S.p.A. (MLM.MI) announces the results of the contribution given by its investigational cell-based therapy TK to the treatment of haematologic malignancies thr…
Amedisys Helps Hospital Partner Reduce Heart Failure Readmission Rate by 13 … – MarketWatch (press release)
Amedisys Helps Hospital Partner Reduce Heart Failure Readmission Rate by 13 …MarketWatch (press release)With the implementation of the Affordable Care Act, which includes a heightened focus on reducing avoidable readmissions, MVH, a community hospita…
Mother backs organ donation drive – Paisley Daily Express
|
Mother backs organ donation drive
Paisley Daily Express “Without a doubt, I wouldn’t have the life or family I have without organ donation and the NHS Organ Donor Register,” she said. “By the time I got to the hospital, my condition was so critical that if a donor hadn’t been found, the outcome for me would … Liver transplant put Richard back on trackshropshirestar.com |
Donahue dies of heart failure – ThisWeekNews
ThisWeekNewsDonahue dies of heart failureThisWeekNewsLongtime ThisWeek Community News reporter and editor Jeffery M. Donahue died early Monday, Feb. 18, due to heart failure. Donahue, most recently special projects editor at ThisWeek who also reported …
Romance Between Man And Organ Donor's Sister – RTT News
|
Romance Between Man And Organ Donor’s Sister
RTT News Romance Between Man And Organ Donor’s Sister. 2/20/2013 10:11 AM ET. An unlikely romance was tipped off between a heart donor’s sister and the recipient of the heart when the latter, so moved by the gift of life, began on a mission to find the person … |
Mother backs organ donation drive – The Paisley Daily Express
|
Mother backs organ donation drive
The Paisley Daily Express “Without a doubt, I wouldn’t have the life or family I have without organ donation and the NHS Organ Donor Register,” she said. “By the time I got to the hospital, my condition was so critical that if a donor hadn’t been found, the outcome for me would … Loss of lives across Worcestershire prompt donor appealBromsgrove Standard Liver transplant put Richard back on trackshropshirestar.com |
Dallas Stars Blood Donation Drive & Promotion – Defending Big D
Dallas Stars Blood Donation Drive & PromotionDefending Big DThe Dallas Stars are promoting blood donation with Carter BloodCare for the rest of February. Carter BloodCare is reaching out to die-hard Dallas Stars fans (like the awesome people who ar…
Linfoma non-Hodgkin. Bendamustina più rituximab meglio della terapia standard – Quotidiano Sanità
|
Linfoma non-Hodgkin. Bendamustina più rituximab meglio della terapia standard
Quotidiano Sanità 20 FEB – L’associazione bendamustina più rituximab (B-R) in pazienti con linfoma non-Hodgkin indolente e mantellare raddoppia la sopravvivenza libera da progressione di malattia (PFS), rispetto al trattamento standard CHOP (ciclofosfamide, doxorubicina … |
Novartis Drug Zortress® Is First In Over A Decade Approved By FDA To Prevent … – Pharmaceutical Online (press release)
|
Novartis Drug Zortress® Is First In Over A Decade Approved By FDA To Prevent …
Pharmaceutical Online (press release) 15, 2013 /PRNewswire/ — Novartis announced today that the US Food and Drug Administration (FDA) has approved Zortress® (everolimus) for the prophylaxis of organ rejection in adult patients receiving a liver transplant. … of chronic renal failure was … Label Expansion for NVS’ Zortress – Analyst BlogNASDAQ |
Mundipharma's bendamustine plus rituximab doubles PFS in non-Hodgkin … – The Pharma Letter
|
Mundipharma’s bendamustine plus rituximab doubles PFS in non-Hodgkin …
The Pharma Letter Results from the StiL NHL-1 study published in the Lancet today (February 20) show that a first-line treatment regimen of bendamustine (marketed under the trade name Levact by privately-held Swiss drugmaker Mundipharma) plus rituximab (B-R) doubles … |